DNA microarrays for thrombosis and haemochromatosis
Two new microarrays based on state-ofthe- art technology provide molecular genetic risk determination for the frequently occurring hereditary conditions thrombosis and haemochromatosis. The EUROArray FV/FII Direct accurately identifies point mutations in the factor V (factor V Leiden, 1691G>A) and/or factor II (prothrombin) gene (20210G>A), which are the most frequent genetic causes of thrombosis and embolism. […]